A recent study by Liu et al. [29] demonstrated a similar result, and reported that regorafenib triggered the intrinsic and extrinsic apoptotic pathways in colorectal cancer cells by activating caspase-3, -8 and -9 in vitro and in vivo. The gene discussed is CASP3; the disease is colorectal cancer.